CM
IMCR icon

Caption Management’s Immunocore IMCR Stock Holding History

Caption Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48M Sell
172,503
-489,283
-74% -$14.5M 0.03% 558
2026
Q1 		$20M Buy
661,786
+567,402
+601% +$18.4M 0.12% 188
2025
Q4 		$3.28M Sell
94,384
-369,278
-80% -$13M 0.02% 653
2025
Q3 		$16.8M Buy
463,662
+284,159
+158% +$9.65M 0.13% 170
2025
Q2 		$5.63M Buy
179,503
+150,110
+511% +$4.66M 0.06% 367
2025
Q1 		$872K Buy
+29,393
New +$882K 0.01% 963
2024
Q2 		– Sell
-9,212
Closed -$599K – 1322
2024
Q1 		$599K Buy
+9,212
New +$632K 0.01% 841
2023
Q1 		– Sell
-12,000
Closed -$685K – 1288
2022
Q4 		$685K Buy
+12,000
New +$675K 0.01% 857

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Caption Management's IMCR Position: Q2 2026 in Review

Caption Management reduced its Immunocore (IMCR) stake by 74% in Q2 2026, selling an estimated $14.5M and leaving 172,503 shares worth $5.48M. The position accounts for 0.03% of the portfolio, ranked #558.

Caption Management first reported a position in IMCR in Q4 2022 and has held it in 8 quarters since. The position peaked at $20M in Q1 2026. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Caption Management held 172,503 shares of Immunocore worth $5.48M as of Q2 2026.
  • Caption Management sold 489,283 Immunocore shares in Q2 2026, an estimated $14.5M.
  • Immunocore made up 0.03% of Caption Management's portfolio in Q2 2026, its #558 holding.
  • Caption Management first reported a position in Immunocore in Q4 2022 and has held it in 8 quarters since.
  • Caption Management's Immunocore position peaked at $20M in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.